Usage and Effectiveness of the Low Glucose Suspend Feature of the Medtronic Paradigm Veo Insulin Pump
Open Access
- 1 September 2011
- journal article
- research article
- Published by SAGE Publications in Journal of Diabetes Science and Technology
- Vol. 5 (5), 1137-1141
- https://doi.org/10.1177/193229681100500514
Abstract
Background: Sensor-augmented insulin pumps may be programmed to suspend insulin delivery in response to hypoglycemia. The Medtronic Paradigm® Veo™ pump with automatic low glucose suspend (LGS) was released in 2009. Data from 7 months of real-world use of the system were analyzed to assess usage patterns and effectiveness of LGS. Method: Data from 935 patients totaling 49,867 patient days were collected; the LGS feature was on for 82% of these days. A subset of 278 subjects who used the pump for ≥3 months was analyzed separately; these subjects provided 28,401 patient days of data, with LGS used for 92% of the time. Results: The LGS threshold was most commonly set between 50 and 60 mg/dl. A total of 27,216 LGS events occurred, and 60% began in the afternoon or evening. The median duration of LGS events was 9.87 min, 45% lasted for 115 min (equivalent to the full extent of the LGS event between 115 and 120 min). Among the episodes lasting for >115 min, the mean sensor glucose (SG) was 58.8 ± 12.4 mg/dl at LGS activation (time 0), rose to 102.2 ± 52.8 mg/dl by the end of the LGS episode (when insulin delivery was automatically resumed), and was 150.1 ± 68.6 mg/dl at 240 min. In the 278-subject subgroup, LGS usage significantly reduced the number of SG readings 300 mg/dl ( p = 0.001). Conclusions: The LGS feature was on for most of the patient days in the study. Most LGS episodes lasted for 115 min was not observed.Keywords
This publication has 7 references indexed in Scilit:
- Insulin Pump Therapy With Automated Insulin Suspension in Response to HypoglycemiaDiabetes Care, 2011
- Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 DiabetesNew England Journal of Medicine, 2010
- Prolonged Nocturnal Hypoglycemia Is Common During 12 Months of Continuous Glucose Monitoring in Children and Adults With Type 1 DiabetesDiabetes Care, 2010
- Confirmation of Hypoglycemia in the “Dead-In-Bed” Syndrome, as Captured by a Retrospective Continuous Glucose Monitoring SystemEndocrine Practice, 2010
- Parental Attitudes Towards Overnight Closed-Loop Glucose Control in Children with Type 1 DiabetesDiabetes Technology & Therapeutics, 2010
- Is an Automatic Pump Suspension Feature Safe for Children with Type 1 Diabetes? An Exploratory Analysis with a Closed-Loop SystemDiabetes Technology & Therapeutics, 2009
- Preventing Hypoglycemia Using Predictive Alarm Algorithms and Insulin Pump SuspensionDiabetes Technology & Therapeutics, 2009